Telcon RF Pharmaceutical텔콘RF제약
200230 · KOSDAQ · ₩200230 · 텔콘RF제약
₩2,150▲ ₩85 (4.12%)End-of-day · Oct 27, 2026 · End-of-day prices.
Filings
- Major sales or supply contract단일판매ㆍ공급계약체결(자율공시)Oct 26, 2026Open on DART
Predicted impact: Medium
Voluntary disclosure of supply contract; size not given, company revenue is three times its market value
- 5%+ holding report주식등의대량보유상황보고서(약식)Oct 12, 2026Open on DART
Predicted impact: Low· Actual: −8.2% vs sector, volume 1.2× normal (5 trading days)
- Major sales or supply contract단일판매ㆍ공급계약체결(자율공시)Oct 2, 2026Open on DART
- Material Matters Report (Decision on Acquisition of Own Convertible Bonds Before Maturity)주요사항보고서(자기전환사채만기전취득결정)Sep 29, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Jul 31, 2026Open on DART
- Other Market Notice (Largest Shareholder Lock-up Related) (Implementation of Largest Shareholder Lock-up)기타시장안내(최대주주의의무보유관련) (최대주주의 의무보유 이행 관련)Jul 27, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Jul 24, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 16, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 16, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 16, 2026Open on DART
- Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Jul 16, 2026Open on DART
- Other Market Notice (Largest Shareholder Lock-up Related) (Implementation of Largest Shareholder Lock-up)기타시장안내(최대주주의의무보유관련) (최대주주의 의무보유 이행 관련)Jul 15, 2026Open on DART
- Market Notice (Mandatory Holding by Largest Shareholder)기타시장안내(최대주주의의무보유관련)Jul 14, 2026Open on DART
- Change of largest shareholder최대주주변경Jul 14, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jul 14, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Jul 10, 2026Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Jul 6, 2026Open on DART
- Acquisition of shares in another company타법인주식및출자증권취득결정Jul 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 30, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 30, 2026Open on DART
- Trading halt주권매매거래정지해제 (감자 주권 변경상장)Jun 25, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jun 10, 2026Open on DART
- Capital Reduction Completed감자완료Jun 9, 2026Open on DART
- Trading halt주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)May 29, 2026Open on DART
- Material Matters Report (Decision on Acquisition of Own Convertible Bonds Before Maturity)주요사항보고서(자기전환사채만기전취득결정)May 27, 2026Open on DART
- Results of Extraordinary Shareholders' Meeting임시주주총회결과May 21, 2026Open on DART
- Decision on Guarantee of Debt for Another Party타인에대한채무보증결정May 15, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Apr 29, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Apr 29, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Apr 17, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 17, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 17, 2026Open on DART
- Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)Apr 17, 2026Open on DART
- Capital reduction decision주요사항보고서(감자결정)Apr 8, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Apr 7, 2026Open on DART
- Shareholders' meeting called주주총회소집결의 (임시주주총회)Apr 7, 2026Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Apr 7, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 27, 2026Open on DART
- Audit report submitted감사보고서제출Mar 19, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 4, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 4, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Mar 4, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 4, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 4, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Feb 23, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Telcon RF Pharmaceutical / 텔콘RF제약 / 200230 / KRX:200230
Source: KRX statistical information